Christy E. Cauley

Dr. Christy E. Cauley


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2017 in Cancer Cytopathology
Verified
Journal Article
Open access
PDF file
MRMatthew W. Rosenbaum
Matthew W. Rosenbaum
CCChristy E. Cauley
Christy E. Cauley
BKBirte Kulemann
Birte Kulemann
ALAndrew Liss
Andrew Liss
CCCarlos Fernandez‐Del Castillo
Carlos Fernandez‐Del Castillo
MPMartha B. Pitman
Martha B. Pitman
BACKGROUND: Circulating epithelioid cells (CECs), also known as circulating tumor, circulating cancer, circulating epithelial, or circulating nonhematologic cells, are a prognostic factor in various malignancies that can be isolated via various protocols. In the current study, the authors analyzed the cytomorphologic characteristics of CECs isolated by size in a cohort of patients with benign and malignant pancreatic diseases to determine whether cytomorphological features could predict CEC origin.METHODS: Blood samples were collected from 9 healthy controls and 171 patients with pancreatic disease who were presenting for surgical evaluation before treatment. Blood was processed with the ScreenCell size‐based filtration device. Evaluable CECs were analyzed in a blinded fashion for cytomorphologic characteristics, including cellularity; nucleoli; nuclear size, irregularity, variability, and hyperchromasia; and nuclear‐to‐cytoplasmic ratio. Statistical differences between variables were analyzed via the Fisher exact test.RESULTS: No CECs were identified among the 9 normal healthy controls. Of the 115 patients with CECs (positive or suspicious for), 25 had nonmalignant disease and 90 had malignancy. There were no significant differences in any of the cytologic criteria noted between groups divided by benign versus malignant, neoplastic versus nonneoplastic, or pancreatic ductal adenocarcinoma versus neuroendocrine tumor.CONCLUSIONS: CECs were observed in patients with malignant and nonmalignant pancreatic disease, but not in healthy controls. There were no morphologic differences observed between cells from different pancreatic diseases, suggesting that numerous conditions may be associated with CECs in the circulation and that care must be taken not to overinterpret cells identified by cytomorphology as indicative of circulating tumor cells of pancreatic cancer. Additional studies are required to determine the origin and clinical significance of these cells. Cancer Cytopathol 2017;125:332–340. © 2017 American Cancer Society.

15 January 2025 in Journal of Gastrointestinal Surgery
Verified
Journal Article
Closed access
SSStefanie J. Soelling
Stefanie J. Soelling
ARAtziri Rubio-Chavez
Atziri Rubio-Chavez
ZIZoe Ingram
Zoe Ingram
LBLaura Baird
Laura Baird
MBMary E. Brindle
Mary E. Brindle
CCChristy E. Cauley
Christy E. Cauley

16 February 2024 in Journal of Surgical Research
Verified
Journal Article
Closed access
CCChristy E. Cauley
Christy E. Cauley
ASAubrey Samost-Williams
Aubrey Samost-Williams
LPLisa Philpotts
Lisa Philpotts
MBMary Brindle
Mary Brindle
ZCZara Cooper
Zara Cooper
CRChristine S. Ritchie
Christine S. Ritchie

8 June 2021 in The American Surgeon™
Verified
Journal Article
Closed access
PDF file
YQYasmeen Z. Qwaider
Yasmeen Z. Qwaider
NSNaomi M. Sell
Naomi M. Sell
CBChloe Boudreau
Chloe Boudreau
CSCaitlin E. Stafford
Caitlin E. Stafford
RRRocco Ricciardi
Rocco Ricciardi
RGRobert N. Goldstone
Robert N. Goldstone
Screening and early detection reduce morbidity and mortality in colorectal cancer. Our aim is to study the effect of income disparities on the clinical characteristics of patients with colorectal cancer in Massachusetts. Patients were extracted from a database containing all surgically treated colorectal cancers between 2004 and 2015 at a tertiary hospital in Massachusetts. We split patients into 2 groups: “above-median income” and “below-median income” according to the median income of Massachusetts ($74,167). The analysis included 817 patients. The above-median income group consisted of 528 patients (65%) and the below-median income group consisted of 289 patients (35%). The mean age of presentation was 64 ± 15 years for the above-median income group and 67 ± 15 years for the below-median income group (P = .04). Patients with below-median income were screened less often (P < .001) and presented more frequently with metastatic disease (P = .02). Patients with above-median income survived an estimated 15 months longer than those with below-median income (P < .001). The survival distribution was statistically significantly different between the groups for stage III disease (P = .004), but not stages I, II, or IV (P = 1, 1, and .2, respectively). For stage III disease, a lower proportion of below-median income patients received chemotherapy (61% vs. 79%, P = .002) and a higher proportion underwent nonelective surgery (5% vs. 2%, P = .007). In Massachusetts, patients with colorectal cancer residing in lower income areas are screened less, received adjuvant chemotherapy less, and have worse outcomes, especially when analyzing those who present with stage III disease.

7 July 2022 in Annals of Surgery
Verified
Journal Article
Closed access
CCChristy E. Cauley
Christy E. Cauley
RMRachel Moyal-Smith
Rachel Moyal-Smith
RSRobert D. Sinyard
Robert D. Sinyard
SWSteven D. Wexner
Steven D. Wexner
HKHaytham Kaafarani
Haytham Kaafarani
MBMary E. Brindle
Mary E. Brindle
An abstract is unavailable. This article is available as a PDF only.

6 May 2022 in Journal of Gastrointestinal Surgery
Verified
Journal Article
Closed access
PDF file
CCChristy E. Cauley
Christy E. Cauley
DCDavid C. Chang
David C. Chang
SLStuart R. Lipsitz
Stuart R. Lipsitz
MBMary Brindle
Mary Brindle
ZCZara Cooper
Zara Cooper
CRChristine S. Ritchie
Christine S. Ritchie